These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18729016)

  • 1. 5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia.
    Johnson CN; Ahmed M; Miller ND
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):642-54. PubMed ID: 18729016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease.
    Geldenhuys WJ; Van der Schyf CJ
    Expert Rev Neurother; 2009 Jul; 9(7):1073-85. PubMed ID: 19589055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
    Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
    Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a series of benzoxazoles as potent 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1115-7. PubMed ID: 19152787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia.
    Nikiforuk A
    Rev Neurosci; 2014; 25(3):367-82. PubMed ID: 24501158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3214-6. PubMed ID: 19433358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
    Benhamú B; Martín-Fontecha M; Vázquez-Villa H; Pardo L; López-Rodríguez ML
    J Med Chem; 2014 Sep; 57(17):7160-81. PubMed ID: 24850589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT6 receptor antagonists as potential therapeutics for cognitive impairment.
    Rossé G; Schaffhauser H
    Curr Top Med Chem; 2010; 10(2):207-21. PubMed ID: 20166958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT(6) receptor and cognition.
    Codony X; Vela JM; Ramírez MJ
    Curr Opin Pharmacol; 2011 Feb; 11(1):94-100. PubMed ID: 21330210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal chemistry strategies to 5-HT(6) receptor ligands as potential cognitive enhancers and antiobesity agents.
    Holenz J; Pauwels PJ; Díaz JL; Mercè R; Codony X; Buschmann H
    Drug Discov Today; 2006 Apr; 11(7-8):283-99. PubMed ID: 16580970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT6 receptors: a novel target for cognitive enhancement.
    Mitchell ES; Neumaier JF
    Pharmacol Ther; 2005 Dec; 108(3):320-33. PubMed ID: 16005519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT6 receptor ligands as antidementia drugs.
    Mitchell ES
    Int Rev Neurobiol; 2011; 96():163-87. PubMed ID: 21329788
    [No Abstract]   [Full Text] [Related]  

  • 13. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.
    Wesołowska A
    Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Phenoxyalkyltriazine Antagonists for 5-HT
    Sudoł S; Cios A; Jastrzębska-Więsek M; Honkisz-Orzechowska E; Mordyl B; Wilczyńska-Zawal N; Satała G; Kucwaj-Brysz K; Partyka A; Latacz G; Olejarz-Maciej A; Wesołowska A; Handzlik J
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT6 receptor antagonists as treatment for age-related cognitive decline.
    Quiedeville A; Boulouard M; Da Silva Costa-Aze V; Dauphin F; Bouet V; Freret T
    Rev Neurosci; 2014; 25(3):417-27. PubMed ID: 24622786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2,3,4-tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands.
    Chang-Fong J; Rangisetty JB; Dukat M; Setola V; Raffay T; Roth B; Glennon RA
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1961-4. PubMed ID: 15050637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Sulfonylindazoles as potent and selective 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2009 May; 19(9):2413-5. PubMed ID: 19345582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin 5-HT
    Ferrero H; Solas M; Francis PT; Ramirez MJ
    CNS Drugs; 2017 Jan; 31(1):19-32. PubMed ID: 27914038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.
    Esbenshade TA; Fox GB; Cowart MD
    Mol Interv; 2006 Apr; 6(2):77-88, 59. PubMed ID: 16565470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease.
    Wicke K; Haupt A; Bespalov A
    Expert Opin Investig Drugs; 2015; 24(12):1515-28. PubMed ID: 26548316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.